We previously reported the fabrication of pH-responsive strontium sulfite nanoparticles (SSNs) and the application of the nanocarrier to efficaciously transport ROS1 siRNA into tumour cells, demonstrating a significant reduction in tumour volume in a murine breast cancer model [58]. This evidence concerns the gene ROS1 and neoplasm.